Chemo's impact on QoL often outweighs benefit in advanced PCa

Article

Half of men who suffer from late-stage prostate cancer would consider chemotherapy a treatment option, and 65% believe the impact on quality of life outweighs its benefit, according to a new survey released by Us TOO International Prostate Cancer Education & Support Network.

Half of men who suffer from late-stage prostate cancer would consider chemotherapy a treatment option, and 65% believe the impact on quality of life outweighs its benefit, according to a new survey released by Us TOO International Prostate Cancer Education & Support Network.

Nearly two-thirds of patients, caregivers, and physicians surveyed were dissatisfied with the current treatment options for advanced prostate cancer. Of the late-stage patients surveyed, bone pain was the number one concern. Sixty-seven percent of the patients feared they will feel pain as their cancer progresses, and 47% of those who experienced bone pain report that they feel pain all of the time or every day.

The survey of more than 500 prostate cancer patients, caregivers, and physicians highlights the need for better treatment options for late-stage disease, Us TOO said.

Related Videos
Marc Bjurlin, DO, MSc, FACOS, answers a question during a Zoom video interview
Prostate cancer cells dividing | Image Credit: © PRB ARTS - stock.adobe.com
John Michael DiBianco, MD, answers a question during a Zoom video interview
Shaya Taghechian, MD, answers a question during a video interview
Human kidney cross section on science background | Image Credit: © Crystal light - stock.adobe.com
A panel of 4 experts on prostate cancer
Joseph Song, MD, answers a question during a video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.